Table 6.
Spearman correlations between scales in the QLQ-C30 and QLQ-NMIBC24 for 541 NMIBC patients participating in UroLife (divergent validity)
| QLQ-C30 scales | QLQ-NMIBC24 scales | |||||
|---|---|---|---|---|---|---|
| Urinary symptoms (–)a | Malaise (–)a | Future worries (–)a | Bloating and flatulence (–)a | Sexual function (+)a | Male sexual problems (–)a | |
| Physical function (+)a | − 0.23 | − 0.16 | − 0.11 | − 0.13 | 0.24 | − 0.18 |
| Role function (+)a | − 0.33 | − 0.27 | − 0.22 | − 0.23 | 0.14 | − 0.14 |
| Emotional function (+)a | − 0.25 | − 0.24 | − 0.57 | − 0.26 | 0.10 | − 0.12 |
| Cognitive function (+)a | − 0.15 | − 0.20 | − 0.21 | − 0.24 | 0.07 | − 0.17 |
| Social function (+)a | − 0.31 | − 0.26 | − 0.32 | − 0.25 | 0.12 | − 0.14 |
| Global Quality of Life (+)a | − 0.38 | − 0.33 | − 0.37 | − 0.25 | 0.16 | − 0.16 |
| Pain (–)a | 0.35 | 0.27 | 0.31 | 0.25 | − 0.13 | 0.15 |
| Fatigue (–)a | 0.26 | 0.28 | 0.27 | 0.26 | − 0.15 | 0.12 |
| Nausea and vomiting (–)a | 0.14 | 0.36 | 0.10 | 0.17 | − 0.03 | 0.03 |
aThe signs (–) and (+) indicate whether higher scores on this scale are worse or better, respectively